The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
16 Apr 2019
2nd iPAAC Joint Action meeting
The second iPAAC JA meeting was held on 10–11 April 2019 in Belgrade, Serbia.
01 Apr 2019
Early Diagnosis of Cancer - 5 Things You Need to Know – REGISTRATION OPEN
The WP5 Conference Early Diagnosis of Cancer - 5 Things You Need to Know will take place on 20 May 2019 and will be hosted by the Hungarian National Institute of Oncology in Budapest.
19 Feb 2019
WP4 visits in EU countries II
The iPAAC WP4 team continues in visiting EU Member States to collect their experience in the implementation of cancer control programs.
13 Feb 2019
Survey on barriers of early diagnosis of cancer